Edgar Snyder & Associates®
A Law Firm Representing Injured People
Call Us Toll Free 24/7
Published on Feb 01, 2005 by Edgar Snyder

Merck Cancelled Early Vioxx Study


Merck & Co. withdrew Vioxx from the market in September 2004 after study results showed the painkiller doubled patients' risk of heart attack and stroke. But could Merck have uncovered Vioxx's ill effects earlier? The answer, according to previously undisclosed Merck documents, is "yes."

Merck executives have long insisted that they never pursued a clinical trial to directly study the heart risks of Vioxx because other tests they were conducting would supply answers just as quickly. Company documents show that Merck was poised to begin a major cardiovascular study of Vioxx in 2002, but dropped the project just days before researchers planned to submit the study protocol to the Food and Drug Administration. The trial may have provided answers about Vioxx's heart risks to save the lives of thousands of people estimated to have suffered a heart attack or stroke resulting from Vioxx use.

Source: The New York Times: "Merck cancelled an early study of Vioxx" by Barry Meier. February 2005.
Think you have a case?
Think you have a case?
Free Case Review
First Name
Last Name
Briefly describe your injuries

Recent News

Sep 26, 2016
Gear Up, Cool Down, and Stay Safe While Riding This Fall
Sep 16, 2016
Fall and Winter Car Kit
Sep 16, 2016
A New Law May Be Coming for Drivers
Sep 16, 2016
Smartphone Apps for Drivers
Sep 16, 2016
New CDC Tool Will Help Keep Traveling Workers Safe